510(k) Report

510(k) · Cleared

Recalled · 2011

Active Inhibin-a Elisa, Model DSL-10-28100

K002128510(k) TraditionalCleared Dec 5, 2000144-day reviewClass I21 CFR 862.1260Recalls 4

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostic Systems Laboratories, Inc. · NDR Enzyme Immunoassay, Inhibin-A

Cleared on Dec 5, 2000 after a 144-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 1 later device descends from it. It has been recalled 4 times.

Decided
Dec 5, 2000
Review
144 days
Class
Class I
Product code
NDR
Recalls
4
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared200020052010201520202025
  1. This deviceK002128 Active Inhibin-a Elisa, Model DSL-10-28100Diagnostic Systems Laboratories, Inc. · 2000
  2. Descendant · cites it directly · 0 of its ownK070144 Inhibin a Calibrators & Controls on the Access Immunoassay SystemsBeckman Coulter, Inc. · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K070144Inhibin a Calibrators & Controls on the Access Immunoassay SystemsBeckman Coulter, Inc. · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K002128Active Inhibin-a Elisa, Model DSL-10-28100Diagnostic Systems Laboratories, Inc.2000—
+1K070144Inhibin a Calibrators & Controls on the Access Immunoassay SystemsBeckman Coulter, Inc.2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K002128, 2000–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NDR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K070144Inhibin a Calibrators & Controls on the Access Immunoassay SystemsBeckman Coulter, Inc.20070

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 31, 2011Not classifiedZ-2774-2011Process designThe recall was initiated because patient results are falsely elevated by approximately 30% because the reference standard of the Manual Inhibin A ELISA assay has shifted from the assays original calibration. Erroneously elevated results…
Mar 31, 2011Not classifiedZ-2772-2011Process designThe recall was initiated because patient results are falsely elevated by approximately 30% because the reference standard of the Manual Inhibin A ELISA assay has shifted from the assays original calibration. Erroneously elevated results…
Mar 31, 2011Not classifiedZ-2773-2011Process designThe recall was initiated because patient results are falsely elevated by approximately 30% because the reference standard of the Manual Inhibin A ELISA assay has shifted from the assays original calibration. Erroneously elevated results…
Mar 31, 2011Not classifiedZ-2775-2011Process designThe recall was initiated because patient results are falsely elevated by approximately 30% because the reference standard of the Manual Inhibin A ELISA assay has shifted from the assays original calibration. Erroneously elevated results…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K070144 (Beckman Coulter, Inc., 2007) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NDR devices

NDR Enzyme Immunoassay, Inhibin-A: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NDR

FDA has decided no NDR device since 2007.

Median 510(k) review, days · NDR

Too few NDR 510(k)s in any year since 2007 to give a median.

Recalls per year · NDR

3in 2010

2010: 3
2007high 3 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NDR

1in 2022

2009: 12010: 12011: 112016: 12017: 42018: 72021: 12022: 1
2007high 11 (2011) · low 0 (2007)2025

MAUDE reports naming product code NDR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—01
20100—31
20110—011
20120—00
20130—00
20140—00
20150—00
20160—01
20170—04
20180—07
20190—00
20200—00
20210—01
20220—01
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K002128: Active Inhibin-a Elisa, Model DSL-10-28100.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K002128

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026